PHSI Consultants Alan Sekula and Ann Johnson contributed to the May/June 2015 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Alan and Ann review the impact that biosimiliars will have on various stakeholders: drug compendia, payers, wholesalers, pharmacies, and manufacturers.  Click here to read their article entitled “Biosimilars: Facts and Future Decisions”.